Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Hepatitis C direct-acting antiviral agents: changing the paradigm of hepatitis C treatment in HIV-infected patients.

Martel-Laferrière V, Bichoupan K, Dieterich DT.

J Clin Gastroenterol. 2014 Feb;48(2):106-12. doi: 10.1097/MCG.0000000000000010. Review.

PMID:
24172182
2.

Second-wave protease inhibitors: choosing an heir.

Ciesek S, von Hahn T, Manns MP.

Clin Liver Dis. 2011 Aug;15(3):597-609. doi: 10.1016/j.cld.2011.05.014. Epub 2011 Jun 25. Review.

PMID:
21867939
3.

Simeprevir for the treatment of hepatitis C and HIV/hepatitis C co-infection.

Flanagan S, Crawford-Jones A, Orkin C.

Expert Rev Clin Pharmacol. 2014 Nov;7(6):691-704. doi: 10.1586/17512433.2014.956091. Epub 2014 Sep 11. Review.

PMID:
25209158
4.

Treating HCV in HIV 2013: on the cusp of change.

Martel-Laferrière V, Dieterich DT.

Liver Int. 2014 Feb;34 Suppl 1:53-9. doi: 10.1111/liv.12396. Review.

PMID:
24373079
5.

Hepatitis C in HIV-infected patients: impact of direct-acting antivirals.

Bichoupan K, Dieterich DT.

Drugs. 2014 Jun;74(9):951-61. doi: 10.1007/s40265-014-0232-6. Review.

PMID:
24866024
6.

[Treatment of hepatitis C: current status and perspectives].

Pol S, Corouge M.

Rev Prat. 2014 May;64(5):605-12. French.

PMID:
24923038
7.

HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.

Bichoupan K, Dieterich DT, Martel-Laferrière V.

Curr HIV/AIDS Rep. 2014 Sep;11(3):241-9. doi: 10.1007/s11904-014-0217-9. Review.

PMID:
24996617
8.

Rapid progression of antiviral treatments of chronic hepatitis C virus infection.

Pol S, Corouge M, Mallet V, Sogni P.

Minerva Gastroenterol Dietol. 2013 Jun;59(2):161-72.

PMID:
23831907
9.

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors.

Welzel TM, Dultz G, Zeuzem S.

J Hepatol. 2014 Nov;61(1 Suppl):S98-S107. doi: 10.1016/j.jhep.2014.08.014. Epub 2014 Nov 3. Review.

10.

Hepatitis C protease and polymerase inhibitors in development.

Liu-Young G, Kozal MJ.

AIDS Patient Care STDS. 2008 Jun;22(6):449-57. doi: 10.1089/apc.2007.0199. Review.

11.

Regimens for Patients Coinfected with Human Immunodeficiency Virus.

Wyles DL.

Clin Liver Dis. 2015 Nov;19(4):689-706, vi-vii. doi: 10.1016/j.cld.2015.06.008. Epub 2015 Aug 29. Review.

PMID:
26466656
12.

Antiviral drugs and the treatment of hepatitis C.

Jalali Z, Rockstroh JK.

Curr HIV/AIDS Rep. 2012 Jun;9(2):132-8. doi: 10.1007/s11904-012-0111-2. Review.

PMID:
22354528
13.

[Hepatitis C virus: 25 years-old, the end?].

Pol S.

Med Sci (Paris). 2013 Nov;29(11):998-1003. doi: 10.1051/medsci/20132911016. Epub 2013 Nov 20. Review. French.

14.

Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.

Soriano V, Labarga P, Vispo E, Fernández-Montero JV, Barreiro P.

Infect Dis Clin North Am. 2012 Dec;26(4):931-48. doi: 10.1016/j.idc.2012.08.004. Epub 2012 Sep 10.

PMID:
23083825
15.

Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1.

Salmon-Ceron D, Arvieux C, Bourlière M, Cacoub P, Halfon P, Lacombe K, Pageaux GP, Pialoux G, Piroth L, Poizot-Martin I, Rosenthal E, Pol S; French Society of Infectious Diseases; French Association for the Study of the Liver; French AIDS Society; French Society of Internal Medicine.

Liver Int. 2014 Jul;34(6):869-89. doi: 10.1111/liv.12363. Epub 2013 Nov 25.

PMID:
24138548
16.

Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.

Butt AA, Kanwal F.

Clin Infect Dis. 2012 Jan 1;54(1):96-104. doi: 10.1093/cid/cir774. Epub 2011 Dec 7. Review.

PMID:
22156853
17.

New frontiers of HCV therapy in HIV/HCV co-infection.

Amorosa VK.

Curr HIV/AIDS Rep. 2010 Aug;7(3):117-26. doi: 10.1007/s11904-010-0051-7.

PMID:
20563864
18.

Boceprevir, an NS3 protease inhibitor of HCV.

Berman K, Kwo PY.

Clin Liver Dis. 2009 Aug;13(3):429-39. doi: 10.1016/j.cld.2009.05.008. Review.

PMID:
19628159
19.

Prompt arrival of antivirals against hepatitis C for HIV patients.

Barreiro P, Vispo E.

AIDS Rev. 2010 Oct-Dec;12(4):242-3. No abstract available.

PMID:
21344779
20.

Future of hepatitis C therapy: development of direct-acting antivirals.

Dore GJ, Matthews GV, Rockstroh J.

Curr Opin HIV AIDS. 2011 Nov;6(6):508-13. doi: 10.1097/COH.0b013e32834b87f8. Review.

PMID:
21897228

Supplemental Content

Support Center